Distinct contribution of Fc receptors and angiotensin II-dependent pathways in anti-GBM glomerulonephritis.

BACKGROUND The contribution of antibody and/or immune-complex to the pathogenesis of immunologically-mediated glomerulonephritis is not fully understood, although it has been recently clarified that Fc receptors (FcRs) play critical roles in the inflammatory cascade. We therefore re-evaluated the classical model of glomerulonephritis, anti-glomerular basement membrane antibody-induced glomerulonephritis (Anti-GBM GN), from the standpoint of FcRs and also investigated the residual FcR-independent mechanisms. METHODS We adopted an Anti-GBM GN mouse model that has two strains deficient in the FcR gamma chain [gamma(-/-)] or Fc gammaRIIB [RII(-/-)], and analyzed functional (urinary protein, serum creatinine, BUN) and pathological changes of the glomeruli. For the analyses of FcR-independent mechanisms, several doses of nephrotoxic serum were applied, and then mice were treated either with cobra venom factor or an angiotensin II type 1 receptor antagonist in gamma(-/-) mice. RESULTS In gamma(-/-) mice, renal injuries were dramatically attenuated with an absence of polymorphonuclear cell (PMN) influx, while RII(-/-) mice suffered accelerated glomerular injuries in spite of a normal PMN influx. In the absence of FcR-dependent effects in gamma(-/-) mice, the FcR-independent pathway lead to chronic renal damage characterized by mesangial proliferation and progressive expansion of mesangial area, with monocyte/macrophage accumulation and with the expression of alpha smooth muscle actin in the mesangial cells and interstitium. Those injuries in gamma(-/-) mice were not attenuated by the decomplementation, but completely abolished by using an angiotensin II type 1 receptor antagonist. CONCLUSIONS Our results clearly demonstrate that FcRs play a pivotal role in Anti-GBM GN, especially in its acute phase. We further clarified the existence of FcR and complement-independent but antibody-dependent pathway. Furthermore, we found that those pathological changes were strongly related to the renin-angiotensin system.

[1]  M. Turner,et al.  The Fc receptor γ‐chain and the tyrosine kinase Syk are essential for activation of mouse platelets by collagen , 1997, The EMBO journal.

[2]  R. Pawankar,et al.  Nasal mast cells in perennial allergic rhinitics exhibit increased expression of the Fc epsilonRI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells. , 1997, The Journal of clinical investigation.

[3]  T. Matsusaka,et al.  Angiotensin in progressive renal diseases: theory and practice. , 1996, Journal of the American Society of Nephrology : JASN.

[4]  F. Chatani,et al.  TCV-116 inhibits renal interstitial and glomerular injury in glomerulosclerotic rats. , 1996, Kidney international. Supplement.

[5]  R. Largo,et al.  Effects and interactions of endothelin-1 and angiotensin II on matrix protein expression and synthesis and mesangial cell growth. , 1996, Hypertension.

[6]  M. Ono,et al.  Augmented humoral and anaphylactic responses in FcγRII-deficient mice , 1996, Nature.

[7]  A. Matsumori,et al.  Angiotensin II receptor antagonist TCV-116 reduces graft coronary artery disease and preserves graft status in a murine model. A comparative study with captopril. , 1996, Circulation.

[8]  Masaki Sugiura,et al.  Angiotensin II Type 1a Receptor-deficient Mice with Hypotension and Hyperreninemia (*) , 1995, The Journal of Biological Chemistry.

[9]  T. Meyer,et al.  Endothelial cell injury initiates glomerular sclerosis in the rat remnant kidney. , 1995, The Journal of clinical investigation.

[10]  G. Till,et al.  The role of complement in experimental bullous pemphigoid. , 1995, The Journal of clinical investigation.

[11]  W. Fridman,et al.  Regulation of high-affinity IgE receptor-mediated mast cell activation by murine low-affinity IgG receptors. , 1995, The Journal of clinical investigation.

[12]  Y. Kaneda,et al.  In vivo transfection of genes for renin and angiotensinogen into the glomerular cells induced phenotypic change of the mesangial cells and glomerular sclerosis. , 1995, Biochemical and biophysical research communications.

[13]  J. Ravetch.  Fc receptors: Rubor redux , 1994, Cell.

[14]  J. Ravetch,et al.  Fc receptors initiate the Arthus reaction: redefining the inflammatory cascade. , 1994, Science.

[15]  K. Resch,et al.  Intrinsic human glomerular mesangial cells can express receptors for IgG complexes (hFc gamma RIII-A) and the associated Fc epsilon RI gamma-chain. , 1994, Journal of immunology.

[16]  J. Ravetch,et al.  FcR γ chain deletion results in pleiotrophic effector cell defects , 1994, Cell.

[17]  J. Egido,et al.  Evidence for a specific IgA receptor in rat and human mesangial cells. , 1993, Journal of immunology.

[18]  G. Bakris,et al.  Endothelin modulates angiotensin II-induced mitogenesis of human mesangial cells. , 1993, The American journal of physiology.

[19]  A. Gown,et al.  Enhanced expression of "muscle-specific" actin in glomerulonephritis. , 1992, Kidney international.

[20]  T. Mori,et al.  Receptors for IgG complexes activate synthesis of monocyte chemoattractant peptide 1 and colony-stimulating factor 1. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[21]  G. Wolf,et al.  Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells. , 1992, The American journal of pathology.

[22]  R. Harris,et al.  Angiotensin actions in the kidney: renewed insight into the old hormone. , 1991, Kidney international.

[23]  G. Macdonald,et al.  Angiotensin II receptor regulation in anti-glomerular basement membrane nephritis. , 1990, Kidney international.

[24]  B. Hammerberg,et al.  Taenia taeniaeformis: evasion of complement-mediated lysis by early larval stages following activation of the alternative pathway. , 1990, International journal for parasitology.

[25]  R. M. Hays,et al.  Effects of vasoactive agents on uptake of immunoglobulin G complexes by mesangial cells. , 1990, The American journal of physiology.

[26]  J. Kinet,et al.  A macrophage Fcγ receptor and the mast cell receptor for IgE share an identical subunit , 1989, Nature.

[27]  S. Klahr,et al.  Progression of renal disease. , 1988, Seminars in nephrology.

[28]  W. Schürch,et al.  Intermediate filament proteins and actin isoforms as markers for soft tissue tumor differentiation and origin. I. Smooth muscle tumors. , 1987, The American journal of pathology.

[29]  N. Boyce,et al.  Intrarenal hemodynamic alterations induced by anti-GBM antibody. , 1987, Kidney international.

[30]  N. Boyce,et al.  Anti-glomerular basement membrane antibody-induced experimental glomerulonephritis: evidence for dose-dependent, direct antibody and complement-induced, cell-independent injury. , 1985, Journal of immunology.

[31]  D. Adams,et al.  The genetic contribution of the NZB mouse to the renal disease of the NZB x NZW hybrid. , 1977, Clinical and experimental immunology.

[32]  R. Lerner,et al.  THE ROLE OF ANTI-GLOMERULAR BASEMENT MEMBRANE ANTIBODY IN THE PATHOGENESIS OF HUMAN GLOMERULONEPHRITIS , 1967, The Journal of experimental medicine.